Sarah Kathryn Rouan

Director

Sarah Kathryn Rouan (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Viking Therapeutics, Inc. (VKTX). The largest single filing was $890K of VKTX (11,000 sh × $80.89, as filed), executed Oct 25 2024.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 1 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$890K

shares × price, as filed

Last traded

Oct 25 2024

Filed Oct 25 2024

Median ADV $77.4M across their filed names

Open performance→

Volume by month

Buys $0 Sells $890K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 24 months

Most traded names

VKTX

Viking Therapeutics, Inc. VKTX · 0 buys · 1 sell 1 filing

Recent filings

VKTXSALE Viking Therapeutics, Inc. View filing → $890K
11,000 sh × $80.89
Exec Oct 25 2024
Filed Oct 25 2024 · 5:30 PM ET